Can We Create Artificial Blood: Advancements And Challenges

Can blood be created artificially? Perfluorocarbons (PFCs) offer a fascinating possibility in this regard. PFCs represent a category of completely synthetic blood substitutes formulated from compounds containing fluorine and carbon. These substances are chemically inert, meaning they don’t react with the body’s biological systems. What sets PFCs apart is their remarkable ability to outperform both water and blood plasma in terms of dissolving and transporting oxygen. In the lungs, they excel at absorbing oxygen, which they subsequently carry throughout the body, potentially revolutionizing the way we address oxygen transport in medical treatments.

Why is it challenging to develop synthetic blood? The creation of artificial blood presents a complex task. To be effective, synthetic blood must not only be compatible with the human body and efficiently transport oxygen but also possess the ability to facilitate clotting by containing platelets. While some research has made progress in developing synthetic blood that can fulfill these requirements, as of July 7, 2022, there is still no viable substitute available. The quest for synthetic blood continues due to its potential to revolutionize medical treatments and save lives.

What is the current status of artificial blood development? While scientists have made significant strides in this field, a fully functional artificial blood product remains elusive. Instead of attempting to replicate the intricate nature of whole blood and its intricate interplay of components, researchers are concentrating on producing individual blood components. As of December 15, 2021, this approach has yielded promising advances, bringing us closer to the realization of artificial blood.